Bayer AG - ADR (BAYRY) - Bull of the Day

By Zacks.com,  September 21, 2012, 01:00:01 AM EDT

Encouraged by strong second quarter 2012 results, upbeat guidance and a series of positive subsequent developments, we are upgrading Bayer AG ADRs ( BAYRY ) to Outperform. Bayer performed impressively in the second quarter of 2012 driven by increased revenues. Management also raised guidance for 2012 revenues as well as earnings.

Subsequently, Bayer has witnessed a series of positive developments, including progress regarding oncology candidate regorafenib and label expansion efforts for Xarelto. Moreover, the decision of Bayer's HealthCare unit to buy Teva's animal health business in the US is also a positive move.

Consequently, we believe that the current price represents an attractive entry point for long-term investors. Over the last five years, Bayer has traded in a range of 9.1x to 28.3x trailing 12-month earnings. Our target price of $103.00 is based on approximately 15.1x our 2012 EPADS estimate of $6.81.
 
BAYER A G -ADR (BAYRY): Free Stock Analysis Report
 
To read this article on Zacks.com click here.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Stocks

Referenced Stocks: BAYRY



Latest News Video

Private Island on the Thames: $11.7 Million
Private Island on the Thames: $11.7...
Take Control Of Your Wealth
Take Control Of Your Wealth         
How to Avoid Getting Caught Pre-Defection
How to Avoid Getting Caught Pre-Def...
WSJ House of the Week: And the Winner Is…
WSJ House of the Week: And the Winn...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.




Most Active by Volume:

Company Last Sale Change Net / %
PFE $ 29.40 0.24  0.82%
NOK $ 3.86 0.17  4.61%
S $ 7.32 0.10  1.39%
BAC $ 13.27 0.06  0.45%
GE $ 24.33 0.56  2.36%
MU $ 13.76 0.52  3.93%
SIRI $ 3.40 0.06  1.80%
MNKD $ 6.605 0.94  12.40%